# Anavex Life Sciences Corp.: Form 8-K, filed Aug 11, 2026

- Company: [Anavex Life Sciences Corp.](/companies/avxl.md) (CIK 1314052)
- Form: 8-K
- Filed: 2026-08-11
- Accepted by EDGAR: Aug 11, 2026, 17:00 ET
- Period: 2026-08-11
- Accession: 0001731122-26-001042
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1314052/000173112226001042/e7842_8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1314052/000173112226001042/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1314052/000173112226001042/e7842_8-k.htm

Filed Aug 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001731122-26-001042. Last ingested by Listed: Nov 3, 2026, 08:15 ET. No prices; not investment advice.